| The genome architecture of the Collaborative Cross mouse genetic reference population Collaborative Cross Consortium Genetics 190 (2), 389-401, 2012 | 478 | 2012 |
| Role of the sympathetic nervous system in regulation of the sodium glucose cotransporter 2 VB Matthews, RH Elliot, C Rudnicka, J Hricova, L Herat, MP Schlaich Journal of Hypertension 35 (10), 2059-2068, 2017 | 231 | 2017 |
| SGLT2 inhibitor–induced sympathoinhibition: a novel mechanism for cardiorenal protection LY Herat, AL Magno, C Rudnicka, J Hricova, R Carnagarin, NC Ward, ... Basic to Translational Science 5 (2), 169-179, 2020 | 227 | 2020 |
| Autonomic regulation of glucose homeostasis: a specific role for sympathetic nervous system activation R Carnagarin, VB Matthews, LY Herat, JK Ho, MP Schlaich Current diabetes reports 18, 1-10, 2018 | 56 | 2018 |
| Role of microparticles in cardiovascular disease: implications for endothelial dysfunction, thrombosis, and inflammation LM Lugo-Gavidia, D Burger, VB Matthews, JM Nolde, M Galindo Kiuchi, ... Hypertension 77 (6), 1825-1844, 2021 | 55 | 2021 |
| Characterization of retinal vascular and neural damage in a novel model of diabetic retinopathy LY Weerasekera, LA Balmer, R Ram, G Morahan Investigative ophthalmology & visual science 56 (6), 3721-3730, 2015 | 55 | 2015 |
| Current knowledge of IL-6 cytokine family members in acute and chronic kidney disease AL Magno, LY Herat, R Carnagarin, MP Schlaich, VB Matthews Biomedicines 7 (1), 19, 2019 | 52 | 2019 |
| Metabolic dysfunction-associated fatty liver disease (MAFLD)—a condition associated with heightened sympathetic activation R Carnagarin, K Tan, L Adams, VB Matthews, MG Kiuchi, ... International Journal of Molecular Sciences 22 (8), 4241, 2021 | 47 | 2021 |
| Candidate gene study of genetic thrombophilic polymorphisms in pre‐eclampsia and recurrent pregnancy loss in Sinhalese women VHW Dissanayake, ND Sirisena, LY Weerasekera, CG Gammulla, ... Journal of Obstetrics and Gynaecology Research 38 (9), 1168-1176, 2012 | 39 | 2012 |
| Determining the role of SGLT2 inhibition with Empagliflozin in the development of diabetic retinopathy J Matthews, L Herat, J Rooney, E Rakoczy, M Schlaich, VB Matthews Bioscience Reports 42 (3), BSR20212209, 2022 | 37 | 2022 |
| Focusing on Sodium Glucose Cotransporter‐2 and the Sympathetic Nervous System: Potential Impact in Diabetic Retinopathy LY Herat, VB Matthews, PE Rakoczy, R Carnagarin, M Schlaich International journal of endocrinology 2018 (1), 9254126, 2018 | 32 | 2018 |
| Prevalence of genetic thrombophilic polymorphisms in the Sri Lankan population—implications for association study design and clinical genetic testing services VHW Dissanayake, LY Weerasekera, CG Gammulla, RW Jayasekara Experimental and molecular pathology 87 (2), 159-162, 2009 | 30 | 2009 |
| Sodium glucose co-transporter 2 inhibition reduces succinate levels in diabetic mice LY Herat, NC Ward, AL Magno, EP Rakoczy, MG Kiuchi, MP Schlaich, ... World Journal of Gastroenterology 26 (23), 3225, 2020 | 26 | 2020 |
| Targeting features of the metabolic syndrome through sympatholytic effects of SGLT2 inhibition LY Herat, J Matthews, O Azzam, MP Schlaich, VB Matthews Current Hypertension Reports 24 (3), 67-74, 2022 | 23 | 2022 |
| Retinal capillary rarefaction is associated with arterial and kidney damage in hypertension S Frost, JM Nolde, J Chan, A Joyson, C Gregory, R Carnagarin, LY Herat, ... Scientific reports 11 (1), 1001, 2021 | 23 | 2021 |
| Implications of ADAM17 activation for hyperglycaemia, obesity and type 2 diabetes J Matthews, S Villescas, L Herat, M Schlaich, V Matthews Bioscience Reports 41 (5), BSR20210029, 2021 | 18 | 2021 |
| Nocturnal hypertension: a common phenotype in a tertiary clinical setting associated with increased arterial stiffness and central blood pressure JM Nolde, MG Kiuchi, LM Lugo-Gavidia, JK Ho, J Chan, VB Matthews, ... Journal of Hypertension 39 (2), 250-258, 2021 | 18 | 2021 |
| Determining the role of SGLT2 inhibition with dapagliflozin in the development of diabetic retinopathy LY Herat, JR Matthews, WE Ong, EP Rakoczy, MP Schlaich, VB Matthews Frontiers in Bioscience-Landmark 27 (12), 321, 2022 | 16 | 2022 |
| The effect of SGLT2 inhibition on diabetic kidney disease in a model of diabetic retinopathy JR Matthews, MP Schlaich, EP Rakoczy, VB Matthews, LY Herat Biomedicines 10 (3), 522, 2022 | 16 | 2022 |
| Combined renal and common hepatic artery denervation as a novel approach to reduce cardiometabolic risk: technical approach, feasibility and safety in a pre-clinical model MG Kiuchi, K Ganesan, J Keating, R Carnagarin, VB Matthews, LY Herat, ... Clinical Research in Cardiology 110, 740-753, 2021 | 16 | 2021 |
Markus SchlaichDobney Hypertension Centre - Royal Perth Hospital Campus, University of Western Australiaยืนยันอีเมลแล้วที่ uwa.edu.au